Name | TUG-905 |
---|
Description | TUG-905 is a potent GPR40 agonist with an pEC50 value of 7.03. TUG-905 increases hypothalamic cell proliferation and survival. TUG-905 reduces body mass and increases the POMC mRNA expression[1][2]. |
---|---|
Related Catalog | |
Target |
pEC50: 7.03 (GPR40)[1] |
In Vitro | TUG-905 (10 µM;7、13 天) 促进细胞增殖和增加神经母细胞标记物 DCX mRNA 水平[2]。 TUG-905 (10 µM;2、4、24 小时) 增加 Neuro2a (鼠神经母细胞瘤) 细胞中的 GPR40、BDNF 基因表达[2]。 Western Blot Analysis[2] Cell Line: DCX/GFAP positive cells (neurospheres from mouse hypothalamic tissue) Concentration: 10 µM Incubation Time: 7 days Result: Increased mRNA levels of the neuroblast marker, DCX, as well as the number of DCX-immunopositive cells. |
In Vivo | TUG-905 (2.0 μL,1.0 mM;i.c.v.;每天两次,持续 6 天) 可降低体重并表现出减少热量摄入的趋势[1]。 Animal Model: 6 weeks, Male Swiss mice[1] Dosage: 2.0 μL, 1.0 mM Administration: I.c.v.; twice a day for 6 days Result: Reduced body mass and exhibited a trend toward reducing caloric intake, and induced an increase of IL10 and IL6 in the hypothalamus, and increased the POMC mRNA expression. |
References |
No Any Chemical & Physical Properties |